Verition Fund Management LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1454027
GREENWICH, CT
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$4,982,168 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$67,326,269
PutShares
201,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $152,220,097 across 64 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in PRAX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,326,269 | 201,100 | Put | Sole | 2026-08-14 | |
| 2025-06-30 | $4,982,168 | 118,482 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,561,010 | 199,657 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,748,535 | 464,508 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $32,173,548 | 559,151 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $30,950,515 | 748,320 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $33,280,796 | 545,408 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $15,662,840 | 703,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,492,324 | 9,059,839 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,061,002 | 10,487,828 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,396,529 | 2,962,335 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,975,482 | 1,670,371 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,052,779 | 904,308 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | $2,058,568 | 840,232 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $2,413,378 | 236,374 | Shares | Sole | 2022-06-02 | |
| 2021-12-31 | $4,182,172 | 212,293 | Shares | Sole | 2022-05-03 | |
| 2021-09-30 | $7,623,279 | 412,292 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,539,549 | 412,448 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,543,178 | 474,456 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $31,606,569 | 574,456 | Shares | Sole | 2021-02-18 | |
| No filing history on record for this holder in this stock. | ||||||